Altimmune, Inc

Contributing Author

Recent Articles by Altimmune, Inc

Jun-13	Altimmune Announces Multiple Presentations at Upcoming American Diabetes Association's Scientific Sessions ALT GlobeNewswire
May-19	Altimmune Announces Initiation of RECLAIM Phase 2 Trial Evaluating the Efficacy and Safety of Pemvidutide in Alcohol Use Disorder (AUD) ALT GlobeNewswire
May-14	Altimmune to Participate at Two Upcoming Investor Conferences ALT GlobeNewswire
May-13	Altimmune Secures Up to $100 Million in Credit Facility from Hercules Capital ALT GlobeNewswire
May-13	Altimmune Announces First Quarter 2025 Financial Results and Business Update ALT GlobeNewswire
May-08	Altimmune Presents New Analyses Predicting High Rates of MASH Resolution on Biopsy following Pemvidutide Treatment at the EASL International Liver Congress ALT GlobeNewswire
May-06	Altimmune to Report First Quarter 2025 Financial Results and Provide Business Update on May 13, 2025 ALT GlobeNewswire